Neural investigation of the dual role of saccadic eye movements in visual perception

眼跳运动在视觉感知中双重作用的神经研究

基本信息

  • 批准号:
    1261433
  • 负责人:
  • 金额:
    $ 54.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-01 至 2018-11-30
  • 项目状态:
    已结题

项目摘要

Humans are highly visual animals and our daily experiences, memories, and dreams are dominated by our visual sense. To create the continuous and seamless visual experience, humans explore their environment by making three to four eye fixations every second, each followed by a rapid saccadic eye movement to the next object of interest. However, most experiments on vision are conducted with research participants trained to keep their eyes still to remove these saccadic eye movements. Such an approach may not tell us in full how vision works in its naturalistic context where eyes are freely moving. In this project, Dr. Michael Paradiso of Brown University will use single unit recording from monkeys when they make visual decisions about objects appearing during or just after saccadic eye movements. The data are expected to reveal how eye movements alter visual processing and how the brain is able to parse the neural continuum into discrete perceptual block using signals associated with saccades. These experiments are innovative in their integration of behavioral testing in naturalistic paradigms with brain recordings using leading edge multi-electrode technology. The researcher aims to bridge the gap between basic research and our understanding of human visual experience in the real world. Numerous disorders ranging from autism, to dyslexia and schizophrenia exhibit abnormal eye movements. At the present it is unclear how the abnormal eye movements are involved in the disorder, but the proposed project will provide critical data that can serve as a foundation for further studies targeted at specific disorders. Through the project, the researcher will continue to give lectures to K-12 students, collaborate with K-12 teachers on science instruction, and host a discussion group in Brown's Catalyst Program for incoming minority students at Brown University. Finally, Dr. Paradiso will participate in the big data effort by making the data available to support other coordinated NSF efforts that aim to make use of real data in the teaching of STEM related courses and to enable participation in discovery science by those who would otherwise have no access to such data.
人类是高度视觉化的动物,我们的日常经历、记忆和梦想都由我们的视觉主导。 为了创造连续和无缝的视觉体验,人类通过每秒进行三到四次眼睛注视来探索他们的环境,每次注视之后都快速扫视下一个感兴趣的物体。 然而,大多数关于视觉的实验都是在研究参与者中进行的,他们被训练保持眼睛静止以消除这些扫视性眼球运动。 这种方法可能无法完全告诉我们,在眼睛自由运动的自然环境中,视觉是如何工作的。在这个项目中,布朗大学的迈克尔·帕拉迪索博士将使用猴子的单单位记录,当它们对扫视眼球运动期间或之后出现的物体做出视觉决定时。 这些数据有望揭示眼球运动如何改变视觉处理,以及大脑如何能够使用与扫视相关的信号将神经连续体解析为离散的感知块。这些实验是创新的,在他们的整合行为测试在自然主义的范例与大脑记录使用领先的多电极技术。 研究人员旨在弥合基础研究与我们对真实的世界中人类视觉体验的理解之间的差距。 从自闭症到阅读障碍和精神分裂症的许多疾病都表现出异常的眼球运动。 目前还不清楚异常眼球运动是如何参与疾病的,但拟议的项目将提供关键数据,可以作为针对特定疾病的进一步研究的基础。 通过该项目,研究人员将继续为K-12学生讲课,与K-12教师合作进行科学教学,并在布朗大学为即将入学的少数民族学生举办布朗催化剂计划的讨论小组。最后,Paradiso博士将通过提供数据来支持NSF的其他协调工作,从而参与大数据工作,这些工作旨在利用STEM相关课程教学中的真实的数据,并使那些无法获得此类数据的人能够参与发现科学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Paradiso其他文献

Michael Paradiso的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain
Cav3通道和可溶性环氧化物水解酶的单分子双重抑制剂治疗神经性疼痛的IND临床I期试验
  • 批准号:
    10760089
  • 财政年份:
    2023
  • 资助金额:
    $ 54.98万
  • 项目类别:
Skeletal effects of early pubertal suppression and peer-concordant puberty timing in transgender and gender diverse youth
青春期早期抑制和同龄人一致的青春期时机对跨性别和性别多样化青年的骨骼影响
  • 批准号:
    10591361
  • 财政年份:
    2023
  • 资助金额:
    $ 54.98万
  • 项目类别:
Computed tomography muscle size and composition associations with hip and spine bone strength over 4 years: SOMMA-CT
4 年来计算机断层扫描肌肉大小和成分与髋部和脊柱骨强度的关系:SOMMA-CT
  • 批准号:
    10741630
  • 财政年份:
    2023
  • 资助金额:
    $ 54.98万
  • 项目类别:
Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)
化生性乳腺癌 (MBC) 中 PI3K 和 NOS 通路的双重靶向
  • 批准号:
    10739097
  • 财政年份:
    2023
  • 资助金额:
    $ 54.98万
  • 项目类别:
Evaluating the Association between Cardiometabolic Health Over the Lifespan and Vertebral Strength
评估终生心脏代谢健康与椎骨强度之间的关联
  • 批准号:
    10586010
  • 财政年份:
    2023
  • 资助金额:
    $ 54.98万
  • 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
  • 批准号:
    10815882
  • 财政年份:
    2023
  • 资助金额:
    $ 54.98万
  • 项目类别:
Targeting innate immunity for induction of robust renal allograft tolerance
针对先天免疫诱导强大的肾同种异体移植耐受
  • 批准号:
    10622050
  • 财政年份:
    2023
  • 资助金额:
    $ 54.98万
  • 项目类别:
Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
  • 批准号:
    10568717
  • 财政年份:
    2023
  • 资助金额:
    $ 54.98万
  • 项目类别:
Dual-payload antibody-drug conjugate for chemo-immunotherapy of triple-negative breast cancers
用于三阴性乳腺癌化学免疫治疗的双有效负载抗体-药物偶联物
  • 批准号:
    10711488
  • 财政年份:
    2023
  • 资助金额:
    $ 54.98万
  • 项目类别:
Light-directed therapy of squamous cell head and neck cancer with a novel dual-acting chemotherapeutic.
使用新型双作用化疗药物对鳞状细胞头颈癌进行光定向治疗。
  • 批准号:
    10761072
  • 财政年份:
    2023
  • 资助金额:
    $ 54.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了